New York Presbyterian Queens . is a clinical research site located in Flushing, New York, United States 11355.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
New York Presbyterian Queens . has participated in 2 clinical trials.
Therapeutic areas: Atherosclerotic Cardiovascular Disease, Heart Failure With Preserved Ejection Fraction (HFpEF).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Queens . has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Queens . has 2 clinical trials on record. Their work covers Atherosclerotic Cardiovascular Disease, Heart Failure With Preserved Ejection Fraction (HFpEF).
New York Presbyterian Queens . has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.